Price $136.91 |
Market Cap
362.48B
|
Sector Health Care |
Div. Growth
6.60%
|
|
P/E
24.2
|
P/B
6.09
|
P/S
4.46
|
Dividend %
2.60%
|
|
P/CF
-
|
P/FCF
41.0
|
Op. Cash Flow
22.2M
|
FCF
3.3
|
|
Op. Margin
22.10%
|
Net Margin
18.80%
|
ROE
24.40%
|
ROI
17.00%
|
|
ROA
9.90%
|
EPS Growth
-
|
Current Ratio
1.5
|
Debt/Equity
46.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Horizon Pharma PLC (HZNP) | $26.84 | - | - | 3.5B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $4.68 | - | - | 79M | Strong Buy |
| Bioanalytical Systems, Inc. (BASI) | $2.00 | - | - | 15.1M | Strong Buy |
| Lannett Company, Inc. (LCI) | $7.16 | - | - | 364.2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.22 | - | - | 22.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
